Dr. Johnson began his career at Baxter Healthcare Corporation where he emerged as a pioneer in managing the development of cellular and gene therapy products for the treatment of chronic diseases, including diabetes, hemophilia, liver failure and cancer. While at Baxter, Dr. Johnson led the team that developed the TheraCyte cell-encapsulation device, and he is co-inventor on numerous other patents on cell encapsulation devices.